Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

GLP-1 obesity drugs linked to fewer alcohol hospitalizationsHealth — Jul 21, 2026A multi-trial analysis of about 40,700 adults found GLP-1 receptor agonists such as semaglutide and tirzepatide are associated with substantially lower alcohol-related hospital admissions across diabetics, obesity, and alcohol-use disorder groups, with reductions ranging from roughly 26% to 65% depending on the comparison. Experts say the findings hint at a potential role for these weight‑loss and diabetes drugs in treating alcohol-use disorders, though more research is needed to confirm causality and guide use.

Strength Training Reduces Women's Heart Attack Risk 44%Health — Jul 23, 2026Health guidance is shifting toward higher-activity and metabolic-focused strategies: in emergencies, metabolic training with drugs like tirzepatide may stabilize organs and improve outcomes for obese patients; in everyday life, strength training significantly lowers cardiovascular risk for women, with two hours weekly linked to up to a 44% reduction in heart attack risk, while broader evidence calls for higher exercise volumes and protein intake to maximize healthspan and reduce mortality, and swimming remains a premier low‑impact option for cardiovascular fitness and circulation.